Abstract
Aims/hypothesis: Melanocortin 4 receptor (MC4R) mutation is the most common cause of known monogenic obesity in humans. Unexpectedly, humans and rodents with MC4R deficiency do not develop hyperglycaemia despite chronic obesity and insulin resistance. To explain the underlying mechanisms for this phenotype, we determined the role of MC4R in glucose homeostasis in the presence and absence of obesity in mice. Methods: We used global and hypothalamus-specific MC4R-deficient mice to investigate the brain regions that contribute to glucose homeostasis via MC4R. We performed oral, intraperitoneal and intravenous glucose tolerance tests in MC4R-deficient mice that were either obese or weight-matched to their littermate controls to define the role of MC4R in glucose regulation independently of changes in body weight. To identify the integrative pathways through which MC4R regulates glucose homeostasis, we measured renal and adrenal sympathetic nerve activity. We also evaluated glucose homeostasis in adrenaline (epinephrine)-deficient mice to investigate the role of adrenaline in mediating the effects of MC4R in glucose homeostasis. We employed a graded [13C6]glucose infusion procedure to quantify renal glucose reabsorption in MC4R-deficient mice. Finally, we measured the levels of renal glucose transporters in hypothalamus-specific MC4R-deficient mice and adrenaline-deficient mice using western blotting to ascertain the molecular mechanisms underlying MC4R control of glucose homeostasis. Results: We found that obese and weight-matched MC4R-deficient mice exhibited improved glucose tolerance due to elevated glucosuria, not enhanced beta cell function. Moreover, MC4R deficiency selectively in the paraventricular nucleus of the hypothalamus (PVH) is responsible for reducing the renal threshold for glucose as measured by graded [13C6]glucose infusion technique. The MC4R deficiency suppressed renal sympathetic nerve activity by 50% in addition to decreasing circulating adrenaline and renal GLUT2 levels in mice, which contributed to the elevated glucosuria. We further report that adrenaline-deficient mice recapitulated the increased excretion of glucose in urine observed in the MC4R-deficient mice. Restoration of circulating adrenaline in both the MC4R- and adrenaline-deficient mice reversed their phenotype of improved glucose tolerance and elevated glucosuria, demonstrating the role of adrenaline in mediating the effects of MC4R on glucose reabsorption. Conclusions/interpretation: These findings define a previously unrecognised function of hypothalamic MC4R in glucose reabsorption mediated by adrenaline and renal GLUT2. Taken together, our findings indicate that elevated glucosuria due to low sympathetic tone explains why MC4R deficiency does not cause hyperglycaemia despite inducing obesity and insulin resistance. [Figure not available: see fulltext.]
Original language | English |
---|---|
Pages (from-to) | 181-194 |
Number of pages | 14 |
Journal | Diabetologia |
Volume | 64 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2021 |
Bibliographical note
Publisher Copyright:© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
Funding
This study was supported by funding from an Endocrine Fellows Foundation grant to AE. NIDDK/NIH DK113115 and DK122190 grants, in addition to Pilot Research Award and Startup funds from the Department of Medicine, URMC, to KHC. NIH/NHLBI HL084207, Department of Veterans Affairs BX004249, funding from the University of Iowa Fraternal Order of Eagles Diabetes Research Center and the Iowa Neuroscience Institute to KR. NIH instrument grant S10OD025242 to University of Rochester Mass Spectrometry Resource Laboratory. The URMC Pediatric Histology Service is supported by the Department of Pediatrics at the University of Rochester and NHLBI/NIH HL122700 and HL148861 grants to G. H. Deutsch, T. J. Mariani, and G. S. Pryhuber. Acknowledgements Authors’ relationships and activities We thank D. P. Olson (University of Michigan, Ann Arbor, MI, USA), B. B. Lowell (Harvard University, Cambridge, MA, USA) for providing Mc4r loxP/loxP mice; V. Vallon (University of California, San Diego, CA, USA), L. Harrison-Bernard (LSUHSC, New Orleans, LA, USA) for discussion and critical comments on the research design of, and results obtained from, this study; G. Pryhuber, C. Poole and S. Mack (URMC Pediatric Histology Service, Rochester, NY, USA) for their help with cryostat and brain sections; K. Welle (University of Rochester Mass Spectrometry Resource Laboratory, Rochester, NY, USA) for help with the [13 C6 ]glucose assay; V. K. Thomas and J. Zhang (URMC Center for Advanced Light Microscopy and Nanoscopy, Rochester, NY, USA) for help with microscopy. Some of the findings of this study were reported in abstract form at ENDO 2020, Endocrine Society Meeting. The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
Funders | Funder number |
---|---|
Iowa Neuroscience Institute | HL148861, NHLBI/NIH HL122700 |
University of Iowa Fraternal Order of Eagles Diabetes Research Center | |
University of Rochester Mass Spectrometry Resource Laboratory | |
NIH Office of the Director | S10OD025242 |
U.S. Department of Veterans Affairs | BX004249 |
Endocrine Society | |
Harvard Transdisciplinary Research in Energetics and Cancer Center, Harvard University | |
University of California San Diego Health | |
Department of Medicine, University of California, San Francisco | NIH/NHLBI HL084207 |
Endocrine Fellows Foundation | NIDDK/NIH DK113115, DK122190 |
Keywords
- Diabetes
- Endocrinology
- Hypothalamus
- Melanocortin 4 receptor
- Mouse model
- Obesity
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism